NCT00673504 First-Line Gemcitabine Chemotherapy With Our Without Sunitinib In Advanced or Metastatic Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT00667641 Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors Status COMPLETED Phase PHASE1
NCT00667082 NPI-0052 and Vorinostat in Patients With Non-small Cell Lung Cancer, Pancreatic Cancer, Melanoma or Lymphoma Status COMPLETED Phase PHASE1
NCT00666978 Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking Status COMPLETED Phase PHASE4
NCT00662688 Chemotherapy With or Without Dalteparin in Treating Patients With Metastatic Pancreatic Cancer Status TERMINATED Phase PHASE3
NCT00660699 A Feasibility Phase II Study in the Treatment of Resected Cholangiocarcinoma, Gallbladder, Pancreatic and Ampullary Cancers Status COMPLETED Phase PHASE2
NCT00660348 Standard Pain Control or Intrathecal Therapy in Controlling Pain in Patients With Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer Status TERMINATED Phase NA
NCT00658840 Concurrent Chemo-radiotherapy With Capecitabine for Unresectable Locally Advanced Pancreatic Carcinoma Status UNKNOWN Phase PHASE2
NCT00658801 Study of Respiratory Gated Proton Beam Radiotherapy for Inoperable Pancreas Carcinoma Status TERMINATED Phase PHASE1
NCT00655785 Antiangiogenic Peptide Vaccine Therapy With Gemcitabine in Treating Patient With Pancreatic Cancer (Phase1/2) Status COMPLETED Phase PHASE1/PHASE2
NCT00654160 Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer Status COMPLETED Phase PHASE1
NCT00652366 A Dose-Escalation to Rash Study of Tarceva (Erlotinib) Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT00648102 Phase I Study of CDX-1307, hCG-B Vaccine, for Patients With Incurable, Locally Advanced or Metastatic Breast, Colorectal, Pancreatic, Bladder or Ovarian Cancer Status COMPLETED Phase PHASE1
NCT00642733 A Study of First Line Treatment With Tarceva (Erlotinib) in Combination With Gemcitabine in Patients With Locally Advanced Unresectable or Metastatic Pancreatic Cancer Status TERMINATED Phase PHASE4
NCT00640978 Erlotinib and RAD001 (Everolimus) in Patients With Previously Treated Advanced Pancreatic Cancer Status TERMINATED Phase PHASE2
NCT00639925 Antiangiogenic Peptide Vaccine Therapy With Gemcitabine in Treating Patient With Pancreatic Cancer Status UNKNOWN Phase PHASE1